Unicycive Therapeutics(UNCY)
MOUNTAIN VIEW, CABiotechnology
Focus: Unicycive Therapeutics is a publicly traded biotech focused on nephrology treatments, specifically targeting chronic kidney disease in dialysis-dependent patients. The company operates as a lean, focused pipeline organization headquartered in Mountain View, CA.
Profile data last refreshed 10h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About Unicycive Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Unicycive Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Unicycive Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$675K
Pipeline & Clinical Trials
Oxylanthanum Carbonate
Chronic Kidney Disease Requiring Chronic DialysisClinical Trials (1)
NCT06218290A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis
Phase 2Help build intelligence for Unicycive Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.